Deletion of and/or mutations in SMN1 coupled with the inability of SMN2 to compensate for the loss of SMN1 leads to spinal muscular atrophy (SMA), a leading genetic disease of children and infants [21–23]. Here, SMN2 is linked to spinal muscular atrophy.